Secondaries announced 3.23.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Vitae Pharmaceuticals, Inc.
Symbol: VTAE
Price: Last trade $6.73
Trade Date: 3/24
Shares: 4.45 million
Underwriter(s) Piper Jaffray, BMO Capital Markets
Rating=Subscription Needed

Company: Antero Midstream Partners LP
Symbol: AM
Price: Last trade $24.97
Trade Date: 3/24
Shares: 8 million
Underwriter(s) Citigroup
Rating=Subscription Needed